Legis Daily

To advance treatment and cures for blindness and other retinal conditions and to promote competitiveness in the United States through a pilot program to increase funding for translational research, and for other purposes.

USA115th CongressHR-6421| House 
| Updated: 7/18/2018
Pete Sessions

Pete Sessions

Republican Representative

Texas

Cosponsors (20)
Tom O'Halleran (Democratic)Kay Granger (Republican)Pete Olson (Republican)Jim Banks (Republican)Sanford D. Bishop (Democratic)Steve Cohen (Democratic)Tim Walberg (Republican)Mike Bishop (Republican)Kenny Marchant (Republican)Gus M. Bilirakis (Republican)Fred Upton (Republican)Jacky Rosen (Democratic)Anna G. Eshoo (Democratic)Eleanor Holmes Norton (Democratic)Thomas J. Rooney (Republican)Mike Quigley (Democratic)Jeff Fortenberry (Republican)Brian K. Fitzpatrick (Republican)Zoe Lofgren (Democratic)Bradley Scott Schneider (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Faster Treatments and Cures for Eye Diseases Act This bill requires the Department of Health and Human Services to establish a pilot program through which vision impairment research projects are funded by specified bonds.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 18, 2018
Introduced in House
Jul 18, 2018
Referred to the House Committee on Energy and Commerce.
  • July 18, 2018
    Introduced in House


  • July 18, 2018
    Referred to the House Committee on Energy and Commerce.

Health

Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDrug therapyExecutive agency funding and structureFinancial services and investmentsGeneticsGovernment information and archivesGovernment lending and loan guaranteesGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHearing, speech, and vision careInterest, dividends, interest ratesMedical researchPublic-private cooperationResearch administration and fundingResearch and developmentSecuritiesUser charges and fees

To advance treatment and cures for blindness and other retinal conditions and to promote competitiveness in the United States through a pilot program to increase funding for translational research, and for other purposes.

USA115th CongressHR-6421| House 
| Updated: 7/18/2018
Faster Treatments and Cures for Eye Diseases Act This bill requires the Department of Health and Human Services to establish a pilot program through which vision impairment research projects are funded by specified bonds.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 18, 2018
Introduced in House
Jul 18, 2018
Referred to the House Committee on Energy and Commerce.
  • July 18, 2018
    Introduced in House


  • July 18, 2018
    Referred to the House Committee on Energy and Commerce.
Pete Sessions

Pete Sessions

Republican Representative

Texas

Cosponsors (20)
Tom O'Halleran (Democratic)Kay Granger (Republican)Pete Olson (Republican)Jim Banks (Republican)Sanford D. Bishop (Democratic)Steve Cohen (Democratic)Tim Walberg (Republican)Mike Bishop (Republican)Kenny Marchant (Republican)Gus M. Bilirakis (Republican)Fred Upton (Republican)Jacky Rosen (Democratic)Anna G. Eshoo (Democratic)Eleanor Holmes Norton (Democratic)Thomas J. Rooney (Republican)Mike Quigley (Democratic)Jeff Fortenberry (Republican)Brian K. Fitzpatrick (Republican)Zoe Lofgren (Democratic)Bradley Scott Schneider (Democratic)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDrug therapyExecutive agency funding and structureFinancial services and investmentsGeneticsGovernment information and archivesGovernment lending and loan guaranteesGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHearing, speech, and vision careInterest, dividends, interest ratesMedical researchPublic-private cooperationResearch administration and fundingResearch and developmentSecuritiesUser charges and fees